Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jen-Chung Ko

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Frontiers in Oncology|November 16, 2020
Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIsChia-Hao Chang, Chih-Hsin Lee, Jen-Chung Ko, et al.
Toxicology Research|May 5, 2022
Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cellsJen-Chung Ko, Jyh-Cheng Chen, Pei-Yu Tseng, et al.
Biochemical Pharmacology|January 23, 2014
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cellsJen-Chung Ko, Hsien-Chun Chiu, Jhan-Jhang Syu, et al.
Future Microbiology|April 12, 2016
Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilitiesMeng-Rui Lee, Chia-Jung Tsai, Jia-Ying Hu, et al.
Basic & Clinical Pharmacology & Toxicology|June 6, 2015
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer CellsJen-Chung Ko, Jhan-Jhang Syu, Jyh-Cheng Chen, et al.
Pharmacology|October 21, 2019
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer CellsJen-Chung Ko, Jyh-Cheng Chen, Ting-Chuan Yen, et al.
Scientific Reports|July 2, 2024
Optimizing immunofluorescence with high-dynamic-range imaging to enhance PD-L1 expression evaluation for 3D pathology assessment from NSCLC tumor tissueHsien-Neng Huang, Chun-Wei Kuo, Yu-Ling Hung, et al.
Insights Into Imaging|April 15, 2023
A deep learning model using chest X-ray for identifying TB and NTM-LD patients: a cross-sectional studyChia-Jung Liu, Cheng Che Tsai, Lu-Cheng Kuo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 8, 2009
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2Jen-Chung Ko, Ying-Jhen Su, Szu-Ting Lin, et al.
Experimental Cell Research|June 10, 2009
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivationRuey-Shyang Chen, Jhih-Yuan Jhan, Ying-Jhen Su, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|November 16, 2020
Effect of β-Blocker in Treatment-Naïve Patients With Advanced Lung Adenocarcinoma Receiving First-Generation EGFR-TKIsChia-Hao Chang, Chih-Hsin Lee, Jen-Chung Ko, et al.
Toxicology Research|May 5, 2022
Nitroglycerin-induced downregulation of AKT- and ERK1/2-mediated radiation-sensitive 52 expression to enhance pemetrexed-induced cytotoxicity in human lung cancer cellsJen-Chung Ko, Jyh-Cheng Chen, Pei-Yu Tseng, et al.
Biochemical Pharmacology|January 23, 2014
Tamoxifen enhances erlotinib-induced cytotoxicity through down-regulating AKT-mediated thymidine phosphorylase expression in human non-small-cell lung cancer cellsJen-Chung Ko, Hsien-Chun Chiu, Jhan-Jhang Syu, et al.
Future Microbiology|April 12, 2016
Acquisition of Mycobacterium abscessus among ventilator-dependent patients in Taiwan chronic respiratory care facilitiesMeng-Rui Lee, Chia-Jung Tsai, Jia-Ying Hu, et al.
Basic & Clinical Pharmacology & Toxicology|June 6, 2015
Resveratrol Enhances Etoposide-Induced Cytotoxicity through Down-Regulating ERK1/2 and AKT-Mediated X-ray Repair Cross-Complement Group 1 (XRCC1) Protein Expression in Human Non-Small-Cell Lung Cancer CellsJen-Chung Ko, Jhan-Jhang Syu, Jyh-Cheng Chen, et al.
Pharmacology|October 21, 2019
Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer CellsJen-Chung Ko, Jyh-Cheng Chen, Ting-Chuan Yen, et al.
Scientific Reports|July 2, 2024
Optimizing immunofluorescence with high-dynamic-range imaging to enhance PD-L1 expression evaluation for 3D pathology assessment from NSCLC tumor tissueHsien-Neng Huang, Chun-Wei Kuo, Yu-Ling Hung, et al.
Insights Into Imaging|April 15, 2023
A deep learning model using chest X-ray for identifying TB and NTM-LD patients: a cross-sectional studyChia-Jung Liu, Cheng Che Tsai, Lu-Cheng Kuo, et al.
Lung Cancer (Amsterdam, Netherlands)|December 8, 2009
Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2Jen-Chung Ko, Ying-Jhen Su, Szu-Ting Lin, et al.
Experimental Cell Research|June 10, 2009
Emodin enhances gefitinib-induced cytotoxicity via Rad51 downregulation and ERK1/2 inactivationRuey-Shyang Chen, Jhih-Yuan Jhan, Ying-Jhen Su, et al.
Pageof 6